The new Hims & Hers Health GLP-1 injections have been announced by the brand thanks to a partnership with a US manufacturer of generic and 503B compounded injectable medications. The brand's addition of the injections will be supported by weight management oral medications to help consumers customize their weight loss journey according to their specific needs. The company has noted that GLP-1 medications can contribute towards a healthy weight loss experience by helping to manage blood sugar levels, curb spontaneous cravings and suppress appetite to make the process of eating less easier.
The company spoke on its new Hims & Hers Health GLP-1 injections saying, "Providing access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic and Wegovy without navigating the shortages and costs that are currently limiting access to the branded medications. Through a partnership with a leading U.S. manufacturer of generic and 503B compounded injectable medications, Hims & Hers can help millions of Americans who have obesity and are looking for help safely managing their weight."